Exercise rehabilitation in patients with cancer

Nature Reviews Clinical Oncology

Volumn 9, Issue 5, 2012, Pages 288-296

  Lakoski, Susan G ^a   Eves, Neil D ^b   Douglas, Pamela S ^c   Jones, Lee W ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; PLATINUM COMPLEX;

ADJUVANT THERAPY; AEROBIC EXERCISE; BLOOD VESSEL FUNCTION; BREAST CANCER; CANCER PATIENT; CANCER REHABILITATION; CARDIOPULMONARY EXERCISE TEST; CARDIOPULMONARY INSUFFICIENCY; CARDIORESPIRATORY FITNESS; EXERCISE; EXERCISE TOLERANCE; FITNESS; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEMATOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG VENTILATION; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; REVIEW; SEDENTARY LIFESTYLE; SIDE EFFECT; SKELETAL MUSCLE;

ADAPTATION, PHYSIOLOGICAL; EXERCISE THERAPY; HUMANS; NEOPLASMS;

EID: 84860385813     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2012.27     Document Type: Review

References (63)

1. Warburton, D. E., Nicol, C. W. & Bredin, S. S. Prescribing exercise as preventative therapy. CMAJ 174, 961-974 (2006).
2. Jones, L. W. & Peppercorn, J. Exercise research: early promise warrants further investment. Lancet Oncol. 11, 408-410 (2010).
3. Gielen, S., Schuler, G. & Adams, V. Cardiovascular effects of exercise training: molecular mechanisms. Circulation 122, 1221-1238 (2010).
4. Jones, L. W., Eves, N. D., Haykowsky, M., Freedland, S. J. & Mackey, J. R. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol. 10, 598-605 (2009).
5. Wagner, P. D. Why doesn't exercise grow the lungs when other factors do? Exerc. Sport Sci. Rev. 33, 3-8 (2005). (Pubitemid 40129890)
6. Hoppeler, H. & Weibel, E. R. Limits for oxygen and substrate transport in mammals. J. Exp. Biol. 201, 1051-1064 (1998). (Pubitemid 28278312)
7. [No authors listed] ATS/ACCP statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 167, 211-277 (2003).
8. Jones, L. W., Eves, N. D., Haykowsky, M., Joy, A. A. & Douglas, P. S. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol. 9, 757-765 (2008). (Pubitemid 352038314)
9. Arena, R. et al. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation 116, 329-343 (2007). (Pubitemid 47196569)
10. Palange, P. et al. Recommendations on the use of exercise testing in clinical practice. Eur. Respir. J. 29, 185-209 (2007). (Pubitemid 46092015)
11. Loewen, G. M. et al. Preoperative exercise VO2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. J. Thorac. Oncol. 2, 619-625 (2007). (Pubitemid 47171783)
12. Jones, L. W. et al. Effects of aerobic training to improve cardiovascular function and prevent cardiac remodeling after cytotoxic therapy in early breast cancer [abstract]. Proc. American Association for Cancer Research 102nd Annual Meeting, a5024 (2011).
13. Fleg, J. L. et al. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation 112, 674-682 (2005). (Pubitemid 41099046)
14. Fitzgerald, M. D., Tanaka, H., Tran, Z. V. & Seals, D. R. Age-related declines in maximal aerobic capacity in regularly exercising vs. sedentary women: a meta-analysis. J. Appl. Physiol. 83, 160-165 (1997). (Pubitemid 27304745)
15. Jones, L. W., Haykowsky, M. J., Swartz, J. J., Douglas, P. S. & Mackey, J. R. Early breast cancer therapy and cardiovascular injury. J. Am. Coll. Cardiol. 50, 1435-1441 (2007). (Pubitemid 47494586)
16. Bolliger, C. T. et al. Pulmonary function and exercise capacity after lung resection. Eur. Respir. J. 9, 415-421 (1996). (Pubitemid 26117782)
17. Nagamatsu, Y. et al. Long-term recovery of exercise capacity and pulmonary function after lobectomy. J. Thorac. Cardiovasc. Surg. 134, 1273-1278 (2007). (Pubitemid 47633609)
18. Hsia, C. C., Ramanathan, M. & Estrera, A. S. Recruitment of diffusing capacity with exercise in patients after pneumonectomy. Am. Rev. Respir. Dis. 145, 811-816 (1992).
19. Sekine, Y., Behnia, M. & Fujisawa, T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer 37, 95-101 (2002). (Pubitemid 34621464)
20. Travers, J. et al. Mechanisms of exertional dyspnea in patients with cancer. J. Appl. Physiol. 104, 57-66 (2008).
21. Marks, L. B. et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 39, 563-570 (1997). (Pubitemid 27441420)
22. Yeh, E. T. et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109, 3122-3131 (2004).
23. Von Hoff, D. D. et al. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med. 91, 710-717 (1979). (Pubitemid 10218041)
24. Swain, S. M., Whaley, F. S. & Ewer, M. S. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97, 2869-2879 (2003). (Pubitemid 36605157)
25. Jones, L. W. et al. Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline taxane containing adjuvant chemotherapy and/or trastuzumab. Cancer Epidemiol. Biomarkers Prev. 16, 1026-1031 (2007). (Pubitemid 46910108)
26. Tassan-Mangina, S. et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur. J. Echocardiogr. 7, 141-146 (2006). (Pubitemid 43257199)
27. Vanoverschelde, J. J. et al. Contribution of left ventricular diastolic function to exercise capacity in normal subjects. J. Appl. Physiol. 74, 2225-2233 (1993).
28. Silvilairat, S., Wongsathikun, J., Sittiwangkul, R., Pongprot, Y. & Chattipakorn, N. Effects of left ventricular function on the exercise capacity in patients with repaired tetralogy of Fallot. Echocardiography 28, 1019-1024 (2011).
29. Zeng, J. et al. Impact of incidental cardiac irradiation on the development of shortness of breath and changes in pulmonary function tests in patients receiving radiation for lung cancer [abstract 1048]. Int. J. Radiat. Oncol. Biol. Phys. 66 (Suppl.), S157-S158 (2006).
30. Hydock, D. S., Lien, C. Y., Schneider, C. M. & Hayward, R. Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats. Am. J. Physiol. Heart Circ. Physiol. 293, H3254-H3264 (2007). (Pubitemid 350230864)
31. Grotto, H. Z. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med. Oncol. 25, 12-21 (2008).
32. Ekblom, B., Goldbarg, A. N. & Gullbring, B. Response to exercise after blood loss and reinfusion. J. Appl. Physiol. 33, 175-180 (1972).
33. Levine, B. D. VO2max: what do we know, and what do we still need to know? J. Physiol. 586, 25-34 (2008).
34. Dolan, L. B. et al. Hemoglobin and aerobic fitness changes with supervised exercise training in breast cancer patients receiving chemotherapy. Cancer Epidemiol. Biomarkers Prev. 19, 2826-2832 (2010).
35. Thijssen, D. H., Green, D. J. & Hopman, M. T. Blood vessel remodeling and physical inactivity in humans. J. Appl. Physiol. 111, 1836-1845 (2011).
36. Palmer, R. M., Ferrige, A. G. & Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526 (1987). (Pubitemid 17085822)
37. Beckman, J. A., Thakore, A., Kalinowski, B. H., Harris, J. R. & Creager, M. A. Radiation therapy impairs endothelium-dependent vasodilation in humans. J. Am. Coll. Cardiol. 37, 761-765 (2001). (Pubitemid 32202442)
38. Chaosuwannakit, N. et al. Aortic stiffness increases upon receipt of anthracycline chemotherapy. J. Clin. Oncol. 28, 166-172 (2010).
39. Galvão, D. A. et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 102, 44-47 (2008). (Pubitemid 351799442)
40. Hydock, D. S., Lien, C. Y., Jensen, B. T., Schneider, C. M. & Hayward, R. Characterization of the effect of in vivo doxorubicin treatment on skeletal muscle function in the rat. Anticancer Res. 31, 2023-2028 (2011).
41. van Norren, K. et al. Direct effects of doxorubicin on skeletal muscle contribute to fatigue. Br. J. Cancer 100, 311-314 (2009).
42. Argilés, J. M., López-Soriano, F. J. & Busquets, S. Mechanisms to explain wasting of muscle and fat in cancer cachexia. Curr. Opin. Support. Palliat. Care 1, 293-298 (2007).
43. Jones, L. W. et al. Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer. J. Thorac. Oncol. 3, 194-195 (2008). (Pubitemid 351323198)
44. Saltin, B. et al. Response to exercise after bed rest and after training. Circulation 38 (Suppl.), VII1-VII78 (1968).
45. Blanchard, C. M., Courneya, K. S. & Stein, K. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J. Clin. Oncol. 26, 2198-2204 (2008).
46. Irwin, M. L. et al. Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97, 1746-1757 (2003). (Pubitemid 36350718)
47. Hsia, C. C. Coordinated adaptation of oxygen transport in cardiopulmonary disease. Circulation 104, 963-969 (2001). (Pubitemid 32778051)
48. Warburton, D. E., Nicol, C. W. & Bredin, S. S. Health benefits of physical activity: the evidence. CMAJ 174, 801-809 (2006).
49. Jones, L. W. et al. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer 116, 4825-4832 (2010).
50. Jones, L. W. et al. Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor-positive operable breast cancer. Oncologist 12, 1156-1164 (2007). (Pubitemid 350106346)
51. Muss, H. B. et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N. Engl. J. Med. 360, 2055-2065 (2009).
52. Schmitz, K. H. et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc. 42, 1409-1426 (2010).
53. Speck, R. M., Courneya, K. S., Mâsse, L. C., Duval, S. & Schmitz, K. H. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J. Cancer Surviv. 5, 87-100 (2010).
54. Jones, L. W. et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist 16, 112-120 (2011).
55. Courneya, K. S. et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J. Clin. Oncol. 25, 4396-4404 (2007). (Pubitemid 350013845)
56. Segal, R. J. et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J. Clin. Oncol. 27, 344-351 (2009).
57. Jones, L. W. et al. The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. BMC Cancer 21, 155 (2010).
58. Jones, L. W. et al. Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer. BMC Cancer 10, 531 (2010).
59. Christensen, J. F. et al. Progressive resistance training and cancer testis (PROTRACT)-efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial. BMC Cancer 11, 326 (2011).
60. Kushi, L. H. et al. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J. Clin. 56, 254-281 (2006). (Pubitemid 44527489)
61. Jones, L. W. Evidence-based risk assessment and recommendations for physical activity clearance: cancer. Appl. Physiol. Nutr. Metab. 36, S101-S112 (2011).
62. Gravely-Witte, S. et al. Effects of cardiac rehabilitation referral strategies on referral and enrollment rates. Nat. Rev. Cardiol. 7, 87-96 (2010).
63. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 7th edn (Lippincott Williams and Wilkins, Philadelphia, 2006).